mary_smiddy

New chief executive for Tonic Life Communications

October 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntsworth Health, mary smiddy, tonic life communications

Healthcare comms consultancy Tonic Life Communications that is a part of the Huntsworth Health family of agencies, has confirmed the …

tarja_stenvall

AstraZeneca president to lead Sanofi UK

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Sanofi, Tarja Stenvall

Sanofi has appointed Tarja Stenvall to be its new general manager for the UK and Ireland. Stenvall joins Sanofi from …

Reverse the odds image

Charity launches second cancer research game

October 9, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds

Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …

Supervisory board member joins Bayer

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler

Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …

Ebola image

Texas Ebola victim dies as diseases spreads

October 9, 2014
Medical Communications, Sales and Marketing Chicago O’Hare, Ebola, Hartsfield-Jackson Atlanta, Newark Liberty, Thomas Eric Duncan, UK, US, Washington Dulles

A Liberian national named Thomas Eric Duncan has died in an isolation ward of a Dallas, Texas hospital after being …

Novartis image

Novartis says three executives departing firm

October 9, 2014
Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines

Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …

stefanie_blasi_rsa_image

RSA makes three appointments

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mateja Forstnaric, Nicholas Draeger, Stefanie Blasi, rsa

Life sciences executive search and interim management firm RSA has appointed three consultants to its European teams.
  Stefanie Blasi (pictured) …

screen_shot_2014-10-08_at_15

European Medicines Group appoints two officers

October 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Garmon-Jones, EMG, Zinta Krumins

The European Medicines Group has elected new chairs to the body in David Garmon-Jones and Zinta Krumins, who will be …

Boris image

Mayor of London calls for dementia R&D centre

October 8, 2014
Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research

The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …

Pharma ‘cannot deliver patient centricity’

October 8, 2014
Research and Development, Sales and Marketing European Brain Council, barcelona, eyeforpharma, mary baker

The former president of the European Brain Council Mary Baker believes pharma companies are focussing too much on patient centricity, …

roy_biresh_verona

Verona Pharma appoints chief financial officer

October 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roy biresh, verona pharma

London-based drug development firm Verona Pharma has hired Biresh Roy as its chief financial officer and member of the board …

ABPI image

Public opinion divided over UK drugs spend

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, UK, coalition, drugs spending, government

A new survey conducted for the ABPI shows that public opinion on whether the UK spends enough money on medicines …

BMS image

BMS pulls hep C combo treatment in US

October 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Combo, HCV, asunaprevir, daclatasvir, hep C, sovaldi

Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …

Triducive appoints senior account manager

October 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Triducive, ian walker, walker, warren

UK healthcare comms consultancy firm Triducive has appointed a new senior account manager in Ian Walker. Walker is a project …

Sovaldi pack shot

Sovaldi ‘unaffordable’ says NHS documents

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing NHS England, fund, hep C, sovaldi

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …

Galderma image

Galderma earns wrath of PMCPA in unprecedented case

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, Azzalure, Galderma, PMCPA, Pliaglis, UK, code of practise

Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely …

MRC commits £60m to new research projects

October 7, 2014
Research and Development, Sales and Marketing MRC, NHS, Parkinson's, Parkinsons, UCL, experimental medicine challenge

Three new research programmes that aim to deliver a step-change in the understanding of disease by using human volunteers in …

owen_mumford_tracey_walker

Owen Mumford promotes and appoints

October 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Owen Mumford, Tracey walker, ceciilia mend, tania mackenzie

Medical device firm Owen Mumford is strengthening its marketing team with three new appointments.   Two of the positions are …

Teva image

Teva to ditch R&D in cancer and women’s health

October 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

Parexel acquires ClinIntel for trial supply services

October 6, 2014
Manufacturing and Production CRO, Paraxel, clinical research organisation, clinintel, manufacturing

Clinical research organisation Parexel has acquired all of the outstanding equity securities of privately-owned ClinIntel, a UK-based provider of clinical …

The Gateway to Local Adoption Series

Latest content